FDA Reauthorization Act of 2017
Became Public Law No: 115-52.
PUB 115-52Became Public Law No: 115-52.
Became Public Law No: 115-52.
![Rep. Walden, Greg [R-OR-2]](https://www.congress.gov/img/member/w000791_200.jpg)
Signed by President.
Signed by President.
Became Public Law No: 115-52.
Became Public Law No: 115-52.
Presented to President.
Presented to President.
Motion to proceed to measure considered in Senate.
Cloture on the motion to proceed to the measure invoked in Senate by Yea-Nay Vote. 96 - 1. Record Vote Number: 185. (CR S4787)
Motion to proceed to consideration of measure agreed to in Senate by Unanimous Consent.
Measure laid before Senate by motion. (consideration: CR S4782-4787)
Passed/agreed to in Senate: Passed Senate without amendment by Yea-Nay Vote. 94 - 1. Record Vote Number: 187.
Passed Senate without amendment by Yea-Nay Vote. 94 - 1. Record Vote Number: 187.
Message on Senate action sent to the House.
Motion to proceed to consideration of measure made in Senate. (CR S4663)
Cloture motion on the motion to proceed to the measure presented in Senate. (CR S4663)
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.
Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
Mr. Walden moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5454-5483)
DEBATE - The House proceeded with forty minutes of debate on H.R. 2430.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5454-5477)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5454-5477)
Motion to reconsider laid on the table Agreed to without objection.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-201.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-201.
Placed on the Union Calendar, Calendar No. 138.
Committee Consideration and Mark-up Session Held.
Ordered to be Reported (Amended) by the Yeas and Nays: 54 - 0.
Subcommittee Consideration and Mark-up Session Held.
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.